Joanne Curley is Chief Development Officer of Vera Therapeutics, Inc.. Currently has a direct ownership of 26,962 shares of VERA, which is worth approximately $1.22 Million. The most recent transaction as insider was on Aug 21, 2023, when has been sold 1,490 shares (Class A Common Stock) at a price of $16.66 per share, resulting in proceeds of $24,823. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27K
0% 3M change
0% 12M change
Total Value Held $1.22 Million

Joanne Curley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 21 2023
SELL
Open market or private sale
$24,823 $16.66 p/Share
1,490 Reduced 5.24%
26,962 Class A Common Stock
Dec 16 2022
SELL
Open market or private sale
$43,465 $19.65 p/Share
2,212 Reduced 7.62%
26,821 Class A Common Stock
Dec 16 2022
BUY
Exercise of conversion of derivative security
$6,414 $2.9 p/Share
2,212 Added 7.42%
27,604 Class A Common Stock
Dec 13 2022
SELL
Open market or private sale
$233,672 $18.24 p/Share
12,811 Reduced 32.32%
26,821 Class A Common Stock
Dec 13 2022
BUY
Exercise of conversion of derivative security
$111,327 $8.69 p/Share
12,811 Added 31.47%
27,899 Class A Common Stock
Dec 12 2022
SELL
Open market or private sale
$125,925 $18.25 p/Share
6,900 Reduced 20.46%
26,821 Class A Common Stock
Dec 12 2022
BUY
Exercise of conversion of derivative security
$75,900 $11.0 p/Share
6,900 Added 16.99%
33,721 Class A Common Stock
Dec 07 2022
SELL
Open market or private sale
$8,136 $16.47 p/Share
494 Reduced 1.81%
26,821 Class A Common Stock
Nov 17 2022
SELL
Open market or private sale
$52,130 $15.85 p/Share
3,289 Reduced 10.75%
27,315 Class A Common Stock
Nov 17 2022
BUY
Exercise of conversion of derivative security
$15,260 $4.64 p/Share
3,289 Added 10.02%
29,526 Class A Common Stock
Nov 09 2022
SELL
Open market or private sale
$8,170 $16.54 p/Share
494 Reduced 1.78%
27,315 Class A Common Stock
Oct 18 2022
SELL
Open market or private sale
$168,708 $19.64 p/Share
8,590 Reduced 23.6%
27,809 Class A Common Stock
Oct 18 2022
BUY
Exercise of conversion of derivative security
$67,174 $7.82 p/Share
8,590 Added 23.6%
27,811 Class A Common Stock
Oct 05 2022
SELL
Open market or private sale
$21,380 $21.64 p/Share
988 Reduced 3.43%
27,809 Class A Common Stock
Sep 21 2022
SELL
Open market or private sale
$25,523 $21.74 p/Share
1,174 Reduced 3.92%
28,797 Class A Common Stock
Sep 21 2022
BUY
Exercise of conversion of derivative security
$12,914 $11.0 p/Share
1,174 Added 3.88%
29,061 Class A Common Stock
Sep 20 2022
SELL
Open market or private sale
$323,660 $20.66 p/Share
15,666 Reduced 35.23%
28,797 Class A Common Stock
Sep 20 2022
BUY
Exercise of conversion of derivative security
$105,902 $6.76 p/Share
15,666 Added 28.71%
38,909 Class A Common Stock
Sep 07 2022
SELL
Open market or private sale
$18,406 $18.63 p/Share
988 Reduced 3.32%
28,797 Class A Common Stock
Aug 22 2022
SELL
Open market or private sale
$31,035 $19.04 p/Share
1,630 Reduced 5.19%
29,785 Class A Common Stock
Aug 22 2022
BUY
Exercise of conversion of derivative security
$17,930 $11.0 p/Share
1,630 Added 5.09%
30,385 Class A Common Stock
Aug 19 2022
SELL
Open market or private sale
$133,413 $19.31 p/Share
6,909 Reduced 18.83%
29,785 Class A Common Stock
Aug 19 2022
BUY
Exercise of conversion of derivative security
$46,705 $6.76 p/Share
6,909 Added 18.38%
30,689 Class A Common Stock
Aug 19 2022
BUY
Grant, award, or other acquisition
-
12,500 Added 29.56%
29,785 Class A Common Stock
Aug 03 2022
SELL
Open market or private sale
$16,608 $16.81 p/Share
988 Reduced 5.41%
17,285 Class A Common Stock

Also insider at

VTGN
VistaGen Therapeutics, Inc. Healthcare
JC

Joanne Curley

Chief Development Officer
Brisbane, CA

Track Institutional and Insider Activities on VERA

Follow Vera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERA shares.

Notify only if

Insider Trading

Get notified when an Vera Therapeutics, Inc. insider buys or sells VERA shares.

Notify only if

News

Receive news related to Vera Therapeutics, Inc.

Track Activities on VERA